MiNK Therapeutics
(NASDAQ:INKT)
$1.03
-0.01[-0.96%]
Last update: 9:29AM Get Real Time Here
Q1 2024 Earnings were released on Tue May 14th, before the market open
The most recent conference call was at 8:30 AM, 3 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

MiNK Therapeutics Stock (NASDAQ:INKT), Quotes and News Summary

MiNK Therapeutics Stock (NASDAQ: INKT) stock price, news, charts, stock research, profile.

Open$1.020
Close-
Volume / Avg.55.648K / 186.303K
Day Range0.980 - 1.035
52 Wk Range0.750 - 3.340
Market Cap$35.745M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
56
Short Interest
0.88%
Days to Cover1.96

Recent News

Why MiNK Therapeutics Stock Is Up 11% Monday
MiNK Therapeutics shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million.
Dylan Berman
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.
Avi Kapoor
Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying
The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Mar
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
INKT
FBIO

FAQ

Q

How do I buy MiNK Therapeutics (INKT) stock?

A

You can purchase shares of MiNK Therapeutics (NASDAQ: INKT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are MiNK Therapeutics's (INKT) competitors?

A

Other companies in MiNK Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and Bolt Biotherapeutics (NASDAQ:BOLT).

Q

What is the target price for MiNK Therapeutics (INKT) stock?

A

The latest price target for MiNK Therapeutics (NASDAQ: INKT) was reported by HC Wainwright & Co. on Tuesday, May 14, 2024. The analyst firm set a price target for 9.00 expecting INKT to rise to within 12 months (a possible 773.79% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for MiNK Therapeutics (INKT)?

A

The stock price for MiNK Therapeutics (NASDAQ: INKT) is $1.03 last updated Today at May 17, 2024 at 9:29 AM EDT.

Q

Does MiNK Therapeutics (INKT) pay a dividend?

A

There are no upcoming dividends for MiNK Therapeutics.

Q

When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?

A

MiNK Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Q

Is MiNK Therapeutics (INKT) going to split?

A

There is no upcoming split for MiNK Therapeutics.

Q

What sector and industry does MiNK Therapeutics (INKT) operate in?

A

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch